Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: Potential relationship to post-therapy tumor angiogenesis and recurrence

International Journal of Cancer

Volumn 105, Issue 2, 2003, Pages 158-164

  Taylor, Alice P ^a,b   Rodriguez, Marisol ^a   Adams, Kelly ^a   Goldenberg, David M ^a   Blumenthal, Rosalyn D ^a  

^a CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

^b GARDEN STATE CANCER CENTER   (United States)

Author keywords

Angiogenesis; Carcinogenesis; Neoplasms; PIGF

Indexed keywords

ANGIOGENIC FACTOR; CARCINOEMBRYONIC ANTIBODY; IMMUNOGLOBULIN G; IODINE 131; MATRIGEL; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MN 14; PLACENTAL GROWTH FACTOR; RS 7 3G11; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTIGENS, CD34; CELL DIVISION; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIAL GROWTH FACTORS; EXTRACELLULAR MATRIX PROTEINS; HEMOGLOBINS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LAMININ; LYMPHOKINES; MICE; MICE, NUDE; MUSCLE, SMOOTH, VASCULAR; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; PREGNANCY PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEOGLYCANS; RADIOIMMUNOTHERAPY; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037431536     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11059     Document Type: Article

References (30)

1. Blumenthal RD, Kashi R, Sharkey RM, Goldenberg DM. Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeability. Int J Cancer 1995;61:557-66.
2. Mauceri HJ, Hanna NN, Beckett MA, Gorski DH, Staba M-J, Stellato KA, Bigelow KA, Heimann R, Gately S, Dhanabal M, Soff GA, Sukhatme VP, et al. Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 1998;394:287-91.
3. Ts'ao C, Molteni A, Taylor JM. Injury-specific cytotoxic response of tumor cells and endothelial cells. Pathol Res Pract 1996;192:1-9.
4. White FC, Carroll SM, Kamps MP. VEGF mRNA is reversibly stabilized by hypoxia and persistently stabilized in VEGF-overexpressing human tumor cell lines. Growth Factors 1995;12:289-301.
5. Gannon G, Mandiroita SJ, Cui L, Baetens D, Pepper MS, Christofori G. Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during beta-cell carcinogenesis. Cancer Res 2002;62:603-8.
6. Donnini S, Machein MR, Plate KH, Weich HA. Expression and localization of placenta growth factor and PIGF receptors in human meningiomas. J Pathol 1999;189:66-71.
7. Korff T, Kimmina S, Martiny-Baron G, Augustin HG. Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J 2001;15:447-57.
8. Taylor AP, Osorio L, Craig R, Raleigh JA, Ying Z, Goldenberg DM, Blumenthal RD. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy. Clin Cancer Res 2002;8:1213-22.
9. Blumenthal RD, Sharkey RM, Kashi R, Sides K, Stein R, Goldenberg DM. Changes in tumor vascular permeability in response to experimental radioimmunotherapy: a comparative study of 11 xenografts. Tumor Biol 1997;18:367-77.
10. Bochner BH, Esrig D, Groshen S, Dickinson M, Weidner N, Nichols PW, Skinner DG, Cote RJ. Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer. Clin Cancer Res 1997;3:1615-22.
11. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogenicity of angiogenesis and blood vessel maturation in human tumors: implications for anti-angiogenic tumor therapy. Cancer Res 2000;60:1388-1393 [Erratum] 3668.
12. Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T, Isner JM. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 1997;8:879-86.
13. Vikkula M, Boon LM, Mulliken JB. Molecular genetics of vascular malformations. Matrix Biol 2001;20:327-35.
14. Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998;125:1591-8.
15. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952-8.
16. Wood HB, May G, Healy L, Enver T, Morriss-Kay GM. CD34 expression patterns during early mouse development are related to modes of blood vessel formation and reveal additional sites of hematopoiesis. Blood 1997;90:2300-11.
17. Ito A, Nomura S, Hirota S, Suda J, Suda T, Kitamura Y. Enhanced expression of CD34 messenger RNA by developing endothelial cells of mice. Lab Invest 1995;72:532-8.
18. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin and fibroblast growth factor. Lab Invest 1992;67:519-28.
19. Blumenthal RD, Sharkey RM, Natale AM, Kashi R, Wong G, Goldenberg DM. Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic xenografts. Cancer Res 1994;54:142-51.
20. 131I-labeled monoclonal antibody RS7-3G11. Antibody Immunconj Radiopharm 1991;4:703-11.
21. Fontanini G, Vignatti S, Boldrini L, Chine S, Silvestri V, Lucchi M, Mussi A, Angeletti A, Bevilacqua G. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small lung carcinoma. Clin Cancer Res 1997;3:861-5.
22. Stratman A, Risqu W, Plate KH. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 1998;153:1459-66.
23. Myoung H, Hong SD, Kim YY, Hong SP, Kim MJ. Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma. Cancer Lett 2001;163:191-200.
24. Nicosia RF, Villaschi S. Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. Lab Invest 1995;73:658-66.
25. Siemeister G, Schirner M, Weindel K, Reusch P, Menrad A, Marme D, Mariny-Baron G. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the tie-2 pathway. Cancer Res 1999;59:3185-91.
26. Augustin HG, Braun K, Telemenakis I, Modlich U, Kuhn W. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am J Pathol 1995;147:339-51.
27. Benjamin LE. Hemo I, Keshet E. A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998;125:1591-8.
28. Ivarsson M, Sundberg C, Farrokhnia N, Pertoft K. Rubin K, Gerdin B. Recruitment of type I collagen producing cells from the microvasculature in vitro. Exp Cell Research 1996;229:335-49.
29. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS. Hendrix MJ. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999;155:739-52.
30. Tsuji T, Sasaki Y, Tanaka M, Hanabata N, Hada R, Munakata A. Microvessel morphology and vascular endothelial growth factor expression in human colonic carcinoma with or without metastasis, Lab Invest 2002:82:555-62.